Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo
Journal of the Pediatric Infectious Diseases Society · 2024
DOI: 10.1093/jpids/piae081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2024. Verfasst von Sahal Thahir und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B, Medication Adherence, Tenofovir. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NICHD NIH HHS, Wellcome Trust.
Abstract (Originalsprache)
Hepatitis B virus (HBV) antiviral administration and adherence are essential to reach the World Health Organization’s 2030 hepatitis elimination goals. As HBV treatment guidelines are now simplified and expanded, adherence to treatment will be critical, but challenges to adherence are poorly studied. After introducing tenofovir disoproxil fumarate (TDF) monotherapy to expectant mothers with high-risk HBV in Kinshasa, DRC, we conducted semi-structured interviews to understand medication adherence behaviors, to complement pill counts and measurement of TDF metabolite levels. Key facilitators of adherence identified included trust in healthcare workers, a better understanding of HBV, and family support. Identified barriers included fear of stigma and low health literacy. Knowledge about HBV disease remains low, underscoring the importance of ongoing education of clinic staff and patients alike.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
- Kinshasa School of Public Health, Kinshasa, Democratic Republic of Congo.
- Department of Gastroenterology, University Hospital, Kinshasa, Democratic Republic of Congo.
- Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, New York City, New York, USA.
- Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
ORCID-Profile: Sahal Thahir, Jonathan B Parr, Peyton Thompson
Förderung
- NIAID NIH HHS
- NICHD NIH HHS
- Wellcome Trust
- Gillings Innovation Laboratory
- University of North Carolina
- Chapel Hill's Gillings School of Global Public Health
- NIH
- NICHD
Zitieren
APA
Thahir, S., Morgan, C. E., Ngimbi, P., Kashamuka, M. M., Ntambua, S., Matondo, J., Tabala, M., Mbendi, C., Kaba, D., Yotebieng, M., Parr, J. B., Banek, K., & Thompson, P. (2024). Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piae081
Vancouver
Thahir S, Morgan CE, Ngimbi P, Kashamuka MM, Ntambua S, Matondo J, et al. Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo. Journal of the Pediatric Infectious Diseases Society. 2024. doi:10.1093/jpids/piae081
BibTeX
@article{Thahir2024,
author = {Thahir, Sahal and Morgan, Camille E and Ngimbi, Patrick and Kashamuka, Melchior Mwandagalirwa and Ntambua, Sarah and Matondo, Jolie and Tabala, Martine and Mbendi, Charles and Kaba, Didine and Yotebieng, Marcel and Parr, Jonathan B and Banek, Kristin and Thompson, Peyton},
title = {Promoting Antiviral Access and Adherence in the Expansion of Hepatitis B Prevention Programs: Insights From the Democratic Republic of Congo},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2024},
doi = {10.1093/jpids/piae081}
}
EUVIMED